Prospective evaluation of the utility of magnetic resonance imaging in patients with non-MRI-conditional pacemakers and defibrillators
© 2020 Wiley Periodicals LLC..
BACKGROUND: Magnetic resonance imaging (MRI) in patients with legacy cardiovascular implantable electronic devices (CIEDs) in situ is likely underutilized. We hypothesized the clinical benefit of MRI would outweigh the risks in legacy CIED patients.
METHODS: This is a single-center retrospective study that evaluated and classified the utility of MRI using a prospectively maintained database. The outcomes were classified as aiding in diagnosis, treatment, or both for the patients attributable to the MRI. We then assessed the incidence of adverse effects (AE) when the MRI was performed.
RESULTS: In 668, MRIs performed on 479 patients, only 13 (1.9%) MRIs did not aid in the diagnosis or treatment of the patient. Power-on reset events without clinical sequelae in three scans (0.45%) were the only AE. The probability of an adverse event happening without any benefit from the MRI scan was 1.1 × 10-4 . A maximum benefit in diagnosis using MRI was obtained in ruling out space-occupying lesions (121/185 scans, 65.4%). Scans performed in patients for elucidating answers to queries in treatment were most frequently done for disease staging at long term follow-up (167/470 scans, 35.5%). Conservative treatment (184/470 scans, 39%) followed by medication changes (153/470 scans, 28.7%) were the most common treatment decisions made.
CONCLUSIONS: The utility of MRI in patients with non-MRI-conditional CIEDs far outweighs the risk of adverse events when imaging is done in the context of a multidisciplinary program that oversees patient safety.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
Journal of cardiovascular electrophysiology - 31(2020), 11 vom: 20. Nov., Seite 2931-2939 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Padmanabhan, Deepak [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cardiovascular implantable electronic devices |
|---|
| Anmerkungen: |
Date Completed 28.07.2021 Date Revised 28.07.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/jce.14705 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM313325871 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM313325871 | ||
| 003 | DE-627 | ||
| 005 | 20231225150331.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/jce.14705 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1044.xml |
| 035 | |a (DE-627)NLM313325871 | ||
| 035 | |a (NLM)32757438 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Padmanabhan, Deepak |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prospective evaluation of the utility of magnetic resonance imaging in patients with non-MRI-conditional pacemakers and defibrillators |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.07.2021 | ||
| 500 | |a Date Revised 28.07.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 Wiley Periodicals LLC. | ||
| 520 | |a BACKGROUND: Magnetic resonance imaging (MRI) in patients with legacy cardiovascular implantable electronic devices (CIEDs) in situ is likely underutilized. We hypothesized the clinical benefit of MRI would outweigh the risks in legacy CIED patients | ||
| 520 | |a METHODS: This is a single-center retrospective study that evaluated and classified the utility of MRI using a prospectively maintained database. The outcomes were classified as aiding in diagnosis, treatment, or both for the patients attributable to the MRI. We then assessed the incidence of adverse effects (AE) when the MRI was performed | ||
| 520 | |a RESULTS: In 668, MRIs performed on 479 patients, only 13 (1.9%) MRIs did not aid in the diagnosis or treatment of the patient. Power-on reset events without clinical sequelae in three scans (0.45%) were the only AE. The probability of an adverse event happening without any benefit from the MRI scan was 1.1 × 10-4 . A maximum benefit in diagnosis using MRI was obtained in ruling out space-occupying lesions (121/185 scans, 65.4%). Scans performed in patients for elucidating answers to queries in treatment were most frequently done for disease staging at long term follow-up (167/470 scans, 35.5%). Conservative treatment (184/470 scans, 39%) followed by medication changes (153/470 scans, 28.7%) were the most common treatment decisions made | ||
| 520 | |a CONCLUSIONS: The utility of MRI in patients with non-MRI-conditional CIEDs far outweighs the risk of adverse events when imaging is done in the context of a multidisciplinary program that oversees patient safety | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a MRI utility | |
| 650 | 4 | |a cardiovascular implantable electronic devices | |
| 650 | 4 | |a magnetic resonance imaging | |
| 650 | 4 | |a non-MRI-conditional devices | |
| 650 | 4 | |a power-on reset | |
| 700 | 1 | |a Kella, Danesh |e verfasserin |4 aut | |
| 700 | 1 | |a Isath, Ameesh |e verfasserin |4 aut | |
| 700 | 1 | |a Tandon, Nidhi |e verfasserin |4 aut | |
| 700 | 1 | |a Mulpuru, Siva |e verfasserin |4 aut | |
| 700 | 1 | |a Deshmukh, Abhishek |e verfasserin |4 aut | |
| 700 | 1 | |a Kapa, Suraj |e verfasserin |4 aut | |
| 700 | 1 | |a Mehta, Ramila |e verfasserin |4 aut | |
| 700 | 1 | |a Dalzell, Connie |e verfasserin |4 aut | |
| 700 | 1 | |a Olson, Nora |e verfasserin |4 aut | |
| 700 | 1 | |a Felmlee, Joel |e verfasserin |4 aut | |
| 700 | 1 | |a Jondal, Mary L |e verfasserin |4 aut | |
| 700 | 1 | |a Asirvatham, Samuel J |e verfasserin |4 aut | |
| 700 | 1 | |a Watson, Robert E |c Jr |e verfasserin |4 aut | |
| 700 | 1 | |a Cha, Yong M |e verfasserin |4 aut | |
| 700 | 1 | |a Friedman, Paul |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of cardiovascular electrophysiology |d 1996 |g 31(2020), 11 vom: 20. Nov., Seite 2931-2939 |w (DE-627)NLM074905481 |x 1540-8167 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2020 |g number:11 |g day:20 |g month:11 |g pages:2931-2939 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/jce.14705 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2020 |e 11 |b 20 |c 11 |h 2931-2939 | ||